D. E. Shaw & Co., Inc. Aerie Pharmaceuticals Inc Put Options Transaction History

D. E. Shaw & Co., Inc.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2020 May 15, 2020	SELL	$11.84 - $25.52 $614,496 - $1.32 Million	-51,900 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $955,479 - $1.45 Million	51,900 New	51,900 $998,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.